Active Ingredient History
Red blood cells (RBCs), also referred to as red cells, red blood corpuscles (in humans or other animals not having nucleus in red blood cells), haematids, erythroid cells or erythrocytes (from Greek erythros 'red' and kytos 'hollow vessel', with -cyte translated as 'cell' in modern usage), are the most common type of blood cell and the vertebrate's principal means of delivering oxygen (O2) to the body tissues—via blood flow through the circulatory system. RBCs take up oxygen in the lungs, or in fish the gills, and release it into tissues while squeezing through the body's capillaries. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia (Phase 3)
Anemia, Sickle Cell (Phase 3)
Angina, Unstable (Phase 3)
Aortic Aneurysm, Abdominal (Phase 2)
Arterial Occlusive Diseases (Phase 2)
Atherosclerosis (Phase 2)
beta-Thalassemia (Phase 3)
Bleeding Time (Phase 3)
Blood Transfusion (Phase 3)
Breast Neoplasms (Phase 3)
Cardiovascular Diseases (Phase 3)
Coronary Artery Disease (Phase 3)
Coronary Vasospasm (Phase 1/Phase 2)
Drugs, Investigational (Phase 2)
Endothelium (Phase 2)
Erythrocyte Transfusion (Phase 4)
General Surgery (Phase 3)
Glucose Transporter Type 1 (Early Phase 1)
Healthy Volunteers (Phase 4)
Heart Diseases (Phase 3)
Hematologic Diseases (Phase 3)
Hemochromatosis (Phase 3)
Hemorrhage (Phase 3)
Hip Fractures (Phase 4)
Hypertension, Pulmonary (Phase 2)
Multiple Trauma (Phase 1/Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myocardial Infarction (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 3)
Nitric Oxide (Phase 2)
Oxidative Stress (Early Phase 1)
Pneumonia (Phase 3)
Postpartum Hemorrhage (Phase 3)
Retinopathy of Prematurity (Phase 2)
Sepsis (Phase 3)
Shock, Hemorrhagic (Phase 3)
Shock, Septic (Phase 3)
Stroke (Phase 3)
Subarachnoid Hemorrhage (Phase 3)
Thoracic Surgery (Phase 3)
Thromboembolism (Phase 3)
Transfusion Reaction (Phase 1)
Traumatology (Phase 3)
Wounds and Injuries (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue